Reuters logo
6 months ago
BRIEF-Bellus Health and the NEOMED Institute announce agreement for development of treatment for chronic cough
February 28, 2017 / 4:16 PM / 6 months ago

BRIEF-Bellus Health and the NEOMED Institute announce agreement for development of treatment for chronic cough

Feb 28 (Reuters) - Bellus Health Inc

* Bellus Health and the NEOMED Institute announce an exclusive worldwide license agreement for the development of a treatment for chronic cough

* Under terms of agreement, Bellus Health will pay neomed an upfront fee of cad $3.2 million

* Upfront fee consists of CAD $1.7 million in cash and CAD $1.5 million with 5.8 million bellus health common shares

* As per agreement, NEOMED will be entitled to receive a royalty on net sales-based revenues Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below